(Total Views: 157)
Posted On: 10/07/2020 10:43:45 AM
Post# of 273337

$NBIO’s top asset is Pritumumab which targets brain, lung, breast, and pancreatic cancer
https://biopharmajournal.com/2020/09/29/why-n...close-look
https://biopharmajournal.com/2020/09/29/why-n...close-look

